|
Novel Glyco-tests to Predict Chemoresistance
|
1R43CA213766-01A1
|
$297,480
|
RAZI, NAHID
|
ACCUDAVA, INC.
|
|
Modulation of Immune Checkpoints by Self-Deliverable RNAi for Adoptive Cell Transfer
|
1R43CA213632-01
|
$231,500
|
WOLFSON, ALEXEY
|
ADVANCED RNA TECHNOLOGIES, LLC
|
|
Core Support for Cancer Center
|
5P30CA013330-45
|
$3,646,138
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Inhibition of Senescence to Increase Cancer Cell Death: A New Paradigm
|
5R01CA077263-18
|
$417,500
|
MCDAID, HAYLEY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
PNNL Proteome Characterization Center
|
5U24CA210955-02
|
$1,091,415
|
LIU, TAO
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
Novel therapeutics for targeting checkpoint dysfunction in cancer
|
1R01CA203824-01A1
|
$362,569
|
LIN, WEEI-CHIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis
|
5R01CA181808-04
|
$336,565
|
RICHARDS, JOANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC
|
5U24CA210954-02
|
$973,045
|
ZHANG, BING
|
BAYLOR COLLEGE OF MEDICINE
|
|
Discovery and Characterization of Mutations in Breast and Ovarian Cancers
|
5R50CA211280-02
|
$215,047
|
ADAMSON, AARON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy
|
5R01CA197359-03
|
$388,875
|
BERLIN, JACOB
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S1
|
$73,297
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S2
|
$124,999
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Molecular Mechanisms of BRCA1-Dependent DNA Damage Response and Tumorogenesis
|
5R01CA132755-10
|
$382,500
|
YU, XIAOCHUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Functional analysis of BRCA1 in DNA damage response and tumor suppression
|
5R01CA187209-04
|
$352,750
|
YU, XIAOCHUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Analysis of BRCA1 Recombination Functions
|
5R01CA095175-13
|
$328,700
|
SCULLY, RALPH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Cancer Deep Phenotype Extraction from Electronic Medical Records
|
7U24CA184407-05
|
$586,963
|
SAVOVA, GUERGANA
|
BOSTON CHILDREN'S HOSPITAL
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
2U01CA164974-07
|
$2,195,369
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5UM1CA164974-06
|
$639,740
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Enzyme-instructed self-assembly for molecular anticancer nanomedicines
|
5R01CA142746-08
|
$368,145
|
XU, BING
|
BRANDEIS UNIVERSITY
|
|
Mucins and immune cell interactions in ovarian cancer pathogenesis & progression
|
5R35CA197605-02
|
$1,031,346
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-18
|
$2,424,605
|
STAMPFER, MEIR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Redefining Normal: personalized CA125 cutpoints for ovarian cancer screening
|
5R01CA193965-02
|
$394,683
|
TERRY, KATHRYN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Theranostic nanoparticles for dual modality cancer therapy
|
5SC2CA206194-03
|
$157,000
|
CZAJKOWSKA, ANETA
|
BROOKLYN COLLEGE
|
|
Impact of social and built environments on health-related quality of life for cancer survivors
|
5R03CA202192-02
|
$74,500
|
SHARIFF-MARCO, SALMA
|
CANCER PREVENTION INSTIT OF CALIFORNIA
|
|
Examining the role of the miR-181a:Wnt/B-catenin axis in ovarian cancer
|
5R01CA197780-02
|
$363,581
|
DIFEO, ANALISA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S1
|
$118,875
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S2
|
$60,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S3
|
$200,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S4
|
$145,821
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-27
|
$4,895,515
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
3U10CA180853-04S1
|
$76,498
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-04
|
$1,188,450
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Identifying epigenetic drivers and their targets in aggressive breast and ovarian cancers
|
5F99CA212460-02
|
$33,366
|
SAHNI (BRANCATO), JENNIFER
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Functional Effects of Ovarian Cancer Risk Variants
|
1R01CA211707-01
|
$686,463
|
GAYTHER, SIMON
|
CEDARS-SINAI MEDICAL CENTER
|
|
The contribution of rare alleles to ovarian cancer in the population
|
5R01CA178535-05
|
$549,009
|
GAYTHER, SIMON
|
CEDARS-SINAI MEDICAL CENTER
|
|
The Role of Splice Quantitative Traits in Ovarian Cancer Pathogenesis
|
1R21CA220078-01
|
$235,553
|
LAWRENSON, KATE
|
CEDARS-SINAI MEDICAL CENTER
|
|
Functional Analysis of LncRNAs in Epithelial Ovarian Cancer
|
5R00CA184415-04
|
$227,414
|
LAWRENSON, KATE
|
CEDARS-SINAI MEDICAL CENTER
|
|
Cancer-Associated Fibroblasts Alter the Composition of B cells in Solid Malignancies
|
5R01CA208753-02
|
$400,313
|
ORSULIC, SANDRA
|
CEDARS-SINAI MEDICAL CENTER
|
|
FOR EDRG WITH CDC/NDI. IT IS FOR NATIONAL DEATH INDEX DATA- NLST & PLCO. 07/20/2017-07/19/2018
|
ACN17006
|
$113,818
|
UNKNOWN, UNKNOWN
|
CENTERS FOR DISEASE CONTROL & PREVENTION
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S4
|
$199,541
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|